BFLYButterfly Network, Inc.
Price
+346%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, a flag to check, growing in the filings, the market undecided.
Butterfly is the pioneer of the Ultrasound-on-Chip™ semiconductor platform and a leader in semiconductor-based point-of-care ultrasound technology. We combine proprietary hardware, intuitive software, services and educational offerings that can make ultrasound more accessible than ever before. Our flagship point-of-care solution enables the practical application of ultrasound information into the clinical workflow through affordable ultrasound devices that fit in a healthcare professional’s pocket and pair with cloud-connected software that is easily accessed through a mobile application.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Butterfly Network, Inc. (BFLY) reported revenue of $33M in Q2 2026 (quarter ended Jun 30, 2026), up 39% from the same quarter a year earlier. That came with a gross margin of 71% and net loss of $13M. For the full year FY2025, revenue was $98M (+19% year on year) and net income −$77M. Its largest product in Q4 2024 (quarter ended Dec 31, 2024) was Service Other at $7.6M, 50.0% of the disclosed total, just ahead of Software And Other Services at 50.0%. The next results filing is expected around Oct 30, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 5, 2026On September 29, 2026, the Board of Directors (the “Board”) of Butterfly Network, Inc. (the “Company”) appointed Michael Noonen to the Board, effective on October 9, 2026 (the “Effective Date”)Director or officer change · Form 8-K
- Aug 11, 2026As previously disclosed in a Current Report on Form 8-K filed by Butterfly Network, Inc. (the “Company”) on May 8, 2026, Dr. Erica Schwartz notified the Company’s Board of Directors (the “Board”) that she would resign as a director of the Company subject to and effective upon her confirmation as Director of the …Director or officer change · Form 8-K
- May 8, 2026On May 4, 2026, Dr. Erica Schwartz notified the Board of Directors (the “Board”) of Butterfly Network, Inc. (the “Company”) that she will resign as a director of the Company subject to and effective upon her confirmation as Director of the Centers for Disease Control and Prevention (the “CDC”) by the U.S. Senate.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q4 2024 · $15.3MThe company’s own SEC segment disclosure.
- Service Other$7.6M50%
- Software And Other Services$7.6M50%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.